One Capital Management LLC Trims Stake in Danaher Co. (NYSE:DHR)

One Capital Management LLC lowered its stake in Danaher Co. (NYSE:DHRFree Report) by 24.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,548 shares of the conglomerate’s stock after selling 496 shares during the period. One Capital Management LLC’s holdings in Danaher were worth $358,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in DHR. Nicholas Hoffman & Company LLC. increased its holdings in Danaher by 2.3% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock worth $439,000 after acquiring an additional 43 shares in the last quarter. Los Angeles Capital Management LLC increased its stake in shares of Danaher by 1.3% during the fourth quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock worth $803,000 after purchasing an additional 43 shares in the last quarter. Berger Financial Group Inc raised its holdings in shares of Danaher by 1.7% during the fourth quarter. Berger Financial Group Inc now owns 2,517 shares of the conglomerate’s stock valued at $582,000 after acquiring an additional 43 shares during the last quarter. Drive Wealth Management LLC lifted its holdings in Danaher by 3.1% in the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock valued at $344,000 after purchasing an additional 44 shares in the last quarter. Finally, Mission Wealth Management LP grew its position in shares of Danaher by 0.4% in the fourth quarter. Mission Wealth Management LP now owns 10,888 shares of the conglomerate’s stock valued at $2,519,000 after purchasing an additional 46 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on DHR. TD Cowen upped their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Citigroup upped their target price on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Royal Bank of Canada lifted their price target on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Robert W. Baird increased their price objective on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a report on Wednesday, April 24th. Finally, Barclays lifted their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a report on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $267.31.

Check Out Our Latest Report on Danaher

Danaher Stock Down 0.6 %

NYSE DHR traded down $1.62 on Monday, reaching $251.76. The company had a trading volume of 821,952 shares, compared to its average volume of 2,683,528. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The firm has a 50-day moving average of $248.07 and a 200-day moving average of $234.03. The firm has a market capitalization of $186.48 billion, a PE ratio of 42.95, a P/E/G ratio of 3.90 and a beta of 0.83. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $259.00.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. Danaher’s quarterly revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.36 EPS. On average, equities research analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.43%. The ex-dividend date of this dividend is Friday, June 28th. Danaher’s dividend payout ratio is presently 18.31%.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the sale, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the transaction, the senior vice president now owns 4,244 shares in the company, valued at approximately $1,029,891.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Walter G. Lohr sold 3,289 shares of the firm’s stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $251.15, for a total value of $826,032.35. Following the completion of the sale, the director now owns 14,129 shares in the company, valued at $3,548,498.35. The disclosure for this sale can be found here. In the last quarter, insiders sold 103,984 shares of company stock worth $25,997,094. 10.90% of the stock is currently owned by corporate insiders.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.